CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that John W. Babich, Ph.D., Interim Chairman and Chief Executive Officer of Molecular Insight Pharmaceuticals, Inc., will participate on a panel called “Tackling Tumors” at the 2008 RBC Capital Markets Healthcare Conference on Wednesday, December 10, 2008. During the panel presentation and discussion, Dr. Babich will provide an overview of the company and its pipeline of molecular imaging radiopharmaceutical and targeted radiotherapeutic candidates for cancer. The panel presentation will take place at 1:30 p.m. Eastern Time at The Westin Times Square Hotel in New York, New York.
